The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria.

Publication Type:
Journal Article
Antimicrobial agents and chemotherapy, 2012, 56 (6), pp. 3244 - 3249
Issue Date:
Full metadata record
Files in This Item:
Filename Description Size
Antimicrob. Agents Chemother.-2012-Skinner-Adams-3244-9.pdfPublished Version810.61 kB
Adobe PDF
Malaria remains a significant risk in many areas of the world, with resistance to the current antimalarial pharmacopeia an ever-increasing problem. The M1 alanine aminopeptidase (PfM1AAP) and M17 leucine aminopeptidase (PfM17LAP) are believed to play a role in the terminal stages of digestion of host hemoglobin and thereby generate a pool of free amino acids that are essential for parasite growth and development. Here, we show that an orally bioavailable aminopeptidase inhibitor, CHR-2863, is efficacious against murine malaria.
Please use this identifier to cite or link to this item: